Skip to main content
Fig. 2 | Journal of Medical Case Reports

Fig. 2

From: Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report

Fig. 2

Epstein–Barr virus viremia showed significant decrease at follow-up. AHSCT allogeneic hematopoietic stem cell transplantation, EBV Epstein–Barr virus, PCR polymerase chain reaction, SMILE dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide

Back to article page